Chula Covid-19 Rapid Test for Pandemic Control

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20200426002

Enrollment

200

Registered

2020-04-26

Start date

2020-04-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibody for Covid&#45

Interventions

Person who are at risk of Covid&#45

19 infection,Healthcare personnels in hospital Patients who will be performed necessary procedures Plan to screening in following steps (1) community hospitals in Thailand (2) Zero or Low PCR confirm

19 prevalence (3) All possible hospital in Thailand

Screening,Screening

Layperson,Hospital related volunteers

Sponsors

Chulalongkorn University

Lead Sponsor

National Cancer Institute of Thailand,Police Hospital,H.R.H. Maha Chakri Sirindhorn Medical Center,Chaophraya Yommaraj Hospital,Nan Hospital,Songkhla Hospital,Lampang Hospital,Sikhio Hospital,Samut Sakhon Hospital,King Prajadhipok Memorial Hospital,King Chulalongkorn Memorial Hospital,Burapha University Hospital,Paholpolpayuhasena Hospital,Samitivej Sukhumvit Hospital,Pattani Provincial Public Health Office,Bangplee Hospital,Chonburi Hospital,Surin Hospital,Child and Adolescent Mental Health Raj

Collaborator

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Healthcare personnels in hospital or 2) Patients who will be performed necessary procedures

Exclusion criteria

Exclusion criteria: PCR confirmed COVID-19 case

Design outcomes

Primary

Measure	Time frame
Antibody to Covid-19 infection at each visit Rapid antibody test kit	—

Secondary

Measure	Time frame
RT-PCR for Covid-19 at each visit RT-PCR,ELISA test for Covid-19 at each visit ELISA	—

Countries

Thailand

Contacts

Public ContactKrit Pongpirul